40
Myris Therapeutics raises $4.5M in Regulation D offering from Sharpsburg biotech
Company raise · Raising · SHARPSBURG, PA · Form D filed 2026-10-14
Myris Therapeutics, a Delaware biotech corporation incorporated in 2022, is raising $4.5M under Regulation D exemption 6(b). The company has sold $500K to four investors so far and is seeking an additional $4M.
other
Why now — by persona
- Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
People on the filing
| Laura E. Benjamin | Executive Officer, Director |
| Rebecca Wolfe | Executive Officer |
| Antonina Simakova | Executive Officer |
| Alan Russell | Promoter |
| David N. Colaizzi | Director |
| Barbara S. Fox | Director |
| Krzysztof Matyjaszewski | Director |
| Mark A. Murcko | Director |
Signed by Laura E. Benjamin, President and Chief Executive Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.